MedPath

Osteopathic Treatment and Deep Vein Thrombosis (DVT)

Not Applicable
Completed
Conditions
Deep Vein Thrombosis (DVT)
Interventions
Other: Osteopathic Treatment
Registration Number
NCT02205294
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

Osteopathic treatment will provide:

1. A significant reduction of pain and swelling of the affected DVT leg

2. An increase in the quality of life (QOL) for individuals with DVT of the leg

3. Improved signs and symptoms of the post thrombotic syndrome of the affected DVT leg

Detailed Description

Thousands of individuals are affected by deep vein thrombosis (DVT) every year. Medical treatment is aimed at preventing extension and recurrence of the blood clot (DVT) through the use of anticoagulation medication. Compression stockings may be added for reduction of pain and swelling, but this therapy remains controversial amongst physicians. To date, there is limited manual therapies available for individuals affected with DVT. Regular medical treatment, anticoagulation medication, along with osteopathic treatment may offer these individuals improved control of the symptoms associated with DVT. In the long term osteopathic treatment may provide an increase in the quality of life (QOL) and improve the signs and symptoms associated with the post-thrombotic syndrome (PTS), which can be burdensome for both the individual and the health care system. Offering an effective add on treatment could provide individuals and the medical system with an additional means of treatment for the symptoms of DVT and also for the prevention of development of PTS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 18 years of age and older
  • first episode of symptomatic objectively confirmed proximal leg DVT without pulmonary embolism
  • 1 month of appropriate anticoagulation treatment
  • therapeutic level of anticoagulation (ie: Warfarin, INR- 2.0-3.0)
Exclusion Criteria
  • > 1 month + 7 days of anticoagulation
  • history of previously confirmed proximal or distal leg DVT
  • medically unstable individuals requiring hospitalization
  • history of peripheral vascular disease (PVD)
  • injury of affected leg (trauma within the last 6 months or leg currently casted)
  • history of previous stroke
  • uncontrolled hypertension
  • renal failure requiring hemodialysis or peritoneal dialysis
  • diagnosis of cancer in the last five years or currently receiving treatment for cancer
  • open heart or vascular surgery in the last year
  • any neurological condition (ie: MS, ALS, Parkinsons, etc)
  • currently pregnant
  • geographic inaccessibility
  • unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Assessment and TreatmentOsteopathic TreatmentSubjects will have an osteopathic assessment to determine areas of tension in specific areas of the body. These areas of tension will receive osteopathic treatment, using myofascial release techniques. These areas include: the thoracic diaphragm, the heart and pericardium, the iliac fascia, the femoral sheath, the sartorius muscle, the pelvic diaphragm and the interosseous membrane (IM) of the lower extremity
Primary Outcome Measures
NameTimeMethod
Swelling1 month pre and post testing and 2 months

Swelling will be measured using a tension-controlled tape measure at the initial study visit, one month after diagnosis of the subject's DVT and then again at 2 months after diagnosis.

Secondary Outcome Measures
NameTimeMethod
Leg Pain1 month pre and post testing and 2 months

Leg Pain will be measured using the visual analogue scale (VAS), at the initial study visit(1 month after diagnosis of the DVT) pre and post assessment or assessment plus treatment. Pain will be evaluated again at the 2 month visit post answering questionnaires and lying supine for 10 minutes.

Trial Locations

Locations (1)

QEll Health Sciences Centre

🇨🇦

Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath